1.Task Sharing between Cardiovascular Surgeons and Nurse Practitioners in Japan: Current Status and Issues
Yuika KAMEDA ; Takahiro ITO ; Taisuke SHIBUYA ; Takao MIKI ; Suguru MIYAZAKI ; Rihito TAMAKI ; Hironobu NISHIORI ; Kaori MORI ; Misato TOKIOKA ; Kazuki TAMURA
Japanese Journal of Cardiovascular Surgery 2025;54(3):3-U1-3-U7
With the full implementation of physician workstyle reform in 2024, task sharing in cardiovascular surgery has become increasingly important. This study conducted a nationwide questionnaire survey targeting young cardiovascular surgeons and nurses certified for specified medical acts to investigate the current status and challenges of task sharing in this field. Results revealed that while nurses were actively involved in postoperative care and certain bedside procedures, their participation in intraoperative and emergency tasks remained limited. From the nurses' perspective, concerns were raised regarding career development, compensation, and the lack of structured educational support. These findings suggest that, to ensure sustainable and effective task sharing in cardiovascular surgery, it is essential to establish clear role definitions and implement systemic organizational support for certified nurses.
2.The Application and Pitfalls for Registering New Japanese Board of Cardiovascular Surgery
Hironobu NISHIORI ; Takahiro ITO ; Kohei TONAI ; Rihito TAMAKI ; Yukika KAMEDA ; Yuta KITAGATA ; Taisuke SHIBUYA ; Takao MIKI ; Go MIYAZAKI ; Kaori MORI ; Misato TOKIOKA
Japanese Journal of Cardiovascular Surgery 2023;52(6):6-U1-6-U6
The first examination of the new board of the Japanese cardiovascular surgery took place in 2022. As it is a transitional period for the new system, many doctors are not familiar with the changes and details of the new system, and some have their concerns. Here, we held a round-table discussion with doctors who actually took the new board of the Japanese cardiovascular surgery under the new system, and we summarized their opinion.
3.Effects of Moxibustion and Goshazinkigan for Spontaneous Fatty II Diabetes Rat
Kaori TAMAKI ; Norimasa TANIGUCHI ; Izuru MATSUHATA ; Shigeyuki KANAI
Kampo Medicine 2005;56(4):555-560
In order to examine the effectiveness of moxibustion and Goshajinkigan for diabetes we investigated using Otsuka Long-Evans Tokushima Fatty (OLETF) rats and Long-Evans Tokushima Otsuka (LETO) rats. 18 male OLETF rats (5 weeks old) and 6 male LETO rats (5 weeks old) were divided into 4 groups. Group I rats were given trial moxibustion (BL 20, BL 23). Group II rats were administered Goshajinkigan (100mg/kg). Group III (OLETF) and IV (OLETF) rats were untreated as controls. In each group, we measured body weight (BW), blood sugar (BS), urine albumin (UA), pain-related time (PRT) and blood flow volume (BFV) before and after the experiment. Moreover, kidney and pancreas tissues were observed.
In groups I, II and III, BW, BS and UA increased in comparison with that of group IV, as the rats grew older. But groups I and II showed suppressed increases, in comparison with that of III group. After stimulation groups I and II showed reaction sensitivity, in comparison with group III. Group I showed a suppressed decrease of BFV. Tissue samples showed no serious change.
These findings suggest that moxibustion and Goshajinkigan inhibited some quantity of the progress of diabetic disease.


Result Analysis
Print
Save
E-mail